G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 100 filers reported holding G1 THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 17.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $595,898 | +2028.2% | 109,339 | +9777.1% | 0.00% | – |
| Q1 2021 | $28,000 | -71.7% | 1,107 | -79.1% | 0.00% | – |
| Q4 2020 | $99,000 | +421.1% | 5,285 | +235.8% | 0.00% | – |
| Q3 2020 | $19,000 | -67.2% | 1,574 | -42.2% | 0.00% | – |
| Q2 2020 | $58,000 | -48.7% | 2,722 | -36.2% | 0.00% | – |
| Q4 2019 | $113,000 | +66.2% | 4,264 | +43.7% | 0.00% | – |
| Q3 2019 | $68,000 | -20.9% | 2,968 | +5.6% | 0.00% | – |
| Q2 2019 | $86,000 | – | 2,811 | +93600.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 3 | -99.1% | 0.00% | – |
| Q4 2018 | $6,000 | -25.0% | 321 | +122.9% | 0.00% | – |
| Q3 2018 | $8,000 | +33.3% | 144 | -0.7% | 0.00% | – |
| Q2 2018 | $6,000 | – | 145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |